GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
-1.38%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$506M
AUM Growth
+$506M
(+4.6%)
Cap. Flow
+$30.4M
Cap. Flow
% of AUM
6%
Top 10 Holdings %
Top 10 Hldgs %
51.22%
Holding
56
New
14
Increased
12
Reduced
14
Closed
12
Top Buys
| 1 |
Cytokinetics
CYTK
|
$17.6M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
$17.4M |
| 3 |
AnaptysBio
ANAB
|
$17.2M |
| 4 |
Evolus
EOLS
|
$16.9M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$13.4M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$20.6M |
| 2 |
Ventyx Biosciences
VTYX
|
$13.1M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$12.5M |
| 4 |
PTC Therapeutics
PTCT
|
$11.5M |
| 5 |
Sarepta Therapeutics
SRPT
|
$9.46M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pliant Therapeutics
PLRX
$101M
| $32.2M | 6.33% | 1,212,096 -110,774 | -8% | -$2.95M |
|
2
Xenon Pharmaceuticals
XENE
$2.98B
| $29.3M | 5.75% | 818,505 -31,495 | -4% | -$1.13M |
|
|
ALPN
3
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $28.9M | 5.67% | 3,740,761 +103,043 | +3% | +$795K |
|
|
4
Ultragenyx Pharmaceutical
RARE
$2.89B
| $27.2M | 5.33% | 677,426 +335,126 | +98% | +$13.4M |
|
5
RAPT Therapeutics
RAPT
$188M
| $24.9M | 4.88% | 1,355,151 -81,418 | -6% | -$1.49M |
|
6
Vaxcyte
PCVX
$4B
| $24.7M | 4.85% | 659,211 -140,789 | -18% | -$5.28M |
|
|
PNT
7
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $24.6M | 4.83% | 3,383,029 +841,250 | +33% | +$6.12M |
|
|
8
Amylyx Pharmaceuticals
AMLX
$836M
| $23M | 4.52% | 783,795 +593,795 | +313% | +$17.4M |
|
9
Travere Therapeutics
TVTX
$1.56B
| $22.6M | 4.43% | 1,003,000 +528,000 | +111% | +$11.9M |
|
10
Jazz Pharmaceuticals
JAZZ
$7.75B
| $21.9M | 4.3% | 149,500 -10,500 | -7% | -$1.54M |
|
|
11
Evolus
EOLS
$494M
| $18.6M | 3.64% | 2,192,816 +2,002,487 | +1,052% | +$16.9M |
|
|
12
Cytokinetics
CYTK
$4.23B
| $17.6M | 3.45% | +500,000 | New | +$17.6M |
|
|
13
AnaptysBio
ANAB
$569M
| $17.5M | 3.44% | 804,333 +789,333 | +5,262% | +$17.2M |
|
|
ISEE
14
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $16.9M | 3.32% | 694,009 -130,991 | -16% | -$3.19M |
|
15
Viking Therapeutics
VKTX
$3.04B
| $16.7M | 3.27% | 1,000,000 -295,034 | -23% | -$4.91M |
|
|
JBIO
16
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $15.2M | 2.99% | 755,620 +377,098 | +100% | +$7.61M |
|
|
OPTN
17
DELISTED
OptiNose
OPTN
| $15.2M | 2.99% | 7,894,736 | – | – |
|
18
Immunocore
IMCR
$1.62B
| $12.6M | 2.48% | +255,367 | New | +$12.6M |
|
19
KalVista Pharmaceuticals
KALV
$678M
| $12.6M | 2.47% | 1,600,545 +544,744 | +52% | +$4.28M |
|
20
Relay Therapeutics
RLAY
$619M
| $10.8M | 2.13% | +658,127 | New | +$10.8M |
|
21
Mineralys Therapeutics
MLYS
$1.03B
| $9.71M | 1.91% | +620,326 | New | +$9.71M |
|
22
Aclaris Therapeutics
ACRS
$209M
| $9.64M | 1.89% | 1,191,581 +172,299 | +17% | +$1.39M |
|
23
Heron Therapeutics
HRTX
$207M
| $8.78M | 1.72% | 5,817,368 -542,793 | -9% | -$820K |
|
24
Arcellx
ACLX
$3.85B
| $7.92M | 1.55% | +257,006 | New | +$7.92M |
|
25
Precision BioSciences
DTIL
$57.8M
| $6.1M | 1.2% | 8,099,799 +4,298,494 | +113% | +$3.24M |
|